The Preparation of Specific Immune Sera against Type 3 Poliovirus D-Antigen and C-Antigen and the Demonstration of Two C-Antigenic Components in Vaccine Strain Populations Free

Abstract

SUMMARY

Animals were immunized with purified D-antigen or C-antigen of type 3 poliovirus to produce specific antisera which were used to analyse the antigenic characteristics of the progeny virus in harvests from poliovirus type 3-infected cells.

An examination of the virus progeny present at 24 h p.i. of cells with Sabin type 3 vaccine strain virus revealed a large population of particles sedimenting at a slightly lower rate (130S) than infectious virus (155S) in addition to slowly sedimenting (80S) empty capsids. Such 130S particles were not detected in the progeny from cells infected with strains genetically unrelated to the Sabin vaccine strains. They were non-infectious, contained RNA in an RNase-resistant form unless heated, and lacked the virion protein VP4. They expressed C-antigen rather than the D-antigen of infectious virus, and, therefore, had the properties previously described for poliovirus particles eluted from cells. The amount of incorporation of radio-isotope into the proteins or nucleic acids of such particles varied from 15 to 20% to 300% of the amount incorporated into infectious virus depending on the cells and virus strains studied. Virus strains genetically related to Sabin type 3 vaccine virus which were isolated from cases of paralytic poliomyelitis produced the particles in either low or undetectable quantities.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-51-1-147
1980-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/51/1/JV0510010147.html?itemId=/content/journal/jgv/10.1099/0022-1317-51-1-147&mimeType=html&fmt=ahah

References

  1. Boulger L. R., Marsden S. A., Magrath D. I., Taffs L. F., Schild G. C. 1979; Comparative monkey neurovirulence of Sabin type III poliovirus vaccines. Journal of Biological Standardization 7:97–111
    [Google Scholar]
  2. De Sena J., Mandel I. B. 1976; Studies on the in vitro uncoating of poliovirus. I. Characterization of the modifying factor and the modifying reaction. Virology 70:470–483
    [Google Scholar]
  3. Dömök I., Magrath D. I. 1979; Guide to poliovirus isolation and serological techniques. World Health Organization publication no. 46
    [Google Scholar]
  4. Fenwick M. L., Cooper P. D. 1962; Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles. Virology 18:212–223
    [Google Scholar]
  5. Fernandez-Tomas C. B., Baltimore D. 1973; Morphogenesis of poliovirus. II. Demonstration of a new intermediate, the provirion. Journal of Virology 12:1122–1130
    [Google Scholar]
  6. Hummeler K., Tumilowicz J. J. 1960; Studies on the complement fixing antigens of poliomyelitis. II. Preparation of type specific anti-N and anti-H-indicator sera. Journal of Immunology 84:630–634
    [Google Scholar]
  7. Joklik W. L., Darnell J. E. 1961; The adsorption and early fate of purified poiliovirus in HeLa cells. Virology 13:439–447
    [Google Scholar]
  8. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  9. Laskey R. A., Mills A. D. 1975; Quantitative film detection of 3H and 14C in polyacrylamide gel by fluorography. European Journal of Biochemistry 56:335–341
    [Google Scholar]
  10. Le Bouvier G. L. 1955; The modification of poliovirus antigens by heat and ultraviolet light. Lancet ii:1013–1016
    [Google Scholar]
  11. Le Bouvier G. L., Schwerdt C. E., Schaffer F. L. 1957; Specific precipitates in agar with purified poliovirus. Virology 4:590–593
    [Google Scholar]
  12. Lonberg-Holm K., Gosser L. B., Kauer J. C. 1975; Early alteration of poliovirus in infected cells and its specific inhibition. Journal of General Virology 27:329–342
    [Google Scholar]
  13. McClaren L. C., Holland J. J. 1974; Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology 60:579–583
    [Google Scholar]
  14. McClure M. A., Holland J. J., Perrault J. 1980; Generation of defective interfering particles in picomaviruses. Virology 100:408–418
    [Google Scholar]
  15. Mayer M. M., Rapp H. J., Roizman B., Klein S. W., Cowan K. M., Lukens D., Schwerdt C. E., Schaffer F. L., Charney J. 1957; The purification of poliomyelitis virus as studied by complement fixation. Journal of Immunology 78:435–455
    [Google Scholar]
  16. Minor P. D. 1980; Comparative biochemical studies of type 3 poliovirus. Journal of Virology 34:73–84
    [Google Scholar]
  17. Sabin A. B., Boulger L. R. 1973; History of Sabin attenuated poliovirus oral live vaccine strains. Journal of Biological Standardization 1:115–118
    [Google Scholar]
  18. Schild G. C., Wood J. M., Minor P. D., Dandawate C. N., Magrath D. I. 1980; Immunoassay of poliovirus antigens by single radial diffusion: development and characteristics of a sensitive autoradiographic zone size enhancement (ZE) technique. Journal of General Virology 51:157–170
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-51-1-147
Loading
/content/journal/jgv/10.1099/0022-1317-51-1-147
Loading

Data & Media loading...

Most cited Most Cited RSS feed